Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;87(4):1684-1694.
doi: 10.1111/bcp.14537. Epub 2020 Sep 15.

Non-medical use of benzodiazepines and GABA analogues in Europe

Joanna Hockenhull  1 , Elise Amioka  2 , Joshua C Black  2 , Alyssa Forber  2 , Colleen M Haynes  2 , David M Wood  1   3 , Richard C Dart  2 , Paul I Dargan  1   3
Affiliations
Free article

Non-medical use of benzodiazepines and GABA analogues in Europe

Joanna Hockenhull et al. Br J Clin Pharmacol. 2021 Apr.
Free article

Abstract

Aims: We investigated the prevalence of non-medical use (NMU) of benzodiazepines and GABA analogues in Europe.

Methods: Data were collected using the online Non-Medical Use of Prescription Drugs (NMURx) survey from France, Germany, Italy, Spain and the UK.

Results: The study included 55 223 eligible surveys which, after post-stratification weights were applied, represented approximately 260 million European adults. Lifetime NMU of benzodiazepines was highest in Spain (6.5%, 95% CI: 6.0-7.0) and lowest in Germany (1.7%, 1.5-2.0). Lifetime NMU of GABA analogues was highest in Germany (5.4%, 5.0-5.7) and lowest in France (2.2%, 1.9-2.5) and the UK (2.2%, 1.9-2.6) While no notable difference was observed for France or the UK, there was a higher prevalence of last 12-month NMU of benzodiazepines compared to GABA analogues in Italy (2.4 times higher) and Spain (3.0 times higher) and a higher prevalence of NMU of GABA analogues compared to benzodiazepines in Germany (2.6 times higher).

Conclusion: This study shows that there is variation in NMU of benzodiazepines and GABA analogues among countries. Of particular interest is the high incidence of GABA analogue NMU in Germany and benzodiazepine NMU in Spain. Further research to identify factors and motivations responsible for the higher prevalence observed are essential to inform public health policies in those countries.

Keywords: addiction; drug abuse; public health.

PubMed Disclaimer

References

REFERENCES

    1. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241-248.
    1. United Nations Office on Drugs and Crime. World Drug Report 2018. Available from: https://wdr.unodc.org/wdr2019/. Accessed February 24, 2020.
    1. Novak SP, Håkansson A, Martinez-Raga J, Reimer J, Krotki K, Varughese S. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry. 2016;16(1):274.
    1. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anesthesio. 2007;20(5):456-472.
    1. Markota M, Morgan RJ. Treatment of generalized anxiety disorder with gabapentin. Case Reports Psychiatr. 2017;2017:1-4.

Publication types

LinkOut - more resources